longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

300683

300683
----

LongbridgeAI

The concept of innovative drugs fluctuates and rebounds, HITECK and ClinPlus rise over 10%

Zhitong
Jul 23, 2025 at 02:04 AM

The innovative drug concept fluctuated and rebounded during the day, with ClinPlus and HITECK rising over 10%. Previously, Nanjing Xinbai and Saili Medical hit the daily limit, while Medicyte, Boteng Co., Ltd., Zhaoyan New Drug, Kanglong Huacheng, and Borui Pharmaceutical rose over 5%

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

ClinPlus

ClinPlus

SZ301257

-4.95%

HITECK

HITECK

SZ300683

-3.89%